Building on an established relationship between the two institutions, South Korea-based International Vaccine Institute ...
Ascletis Pharma has dosed the first participant in its global Phase III clinical programme evaluating ASC30, an investig...
Osivax, a France based clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to...
CanSino Biologics reported continued momentum in its international business during the first half of 2026, alongside pro...
Antengene has received approval in Australia to initiate a Phase I clinical study of ATG-201, its investigational CD19/C...
Drug delivery technologies have become increasingly important as pharmaceutical developers work with complex molecules, ...
US-based Charles River Laboratories International, and Medigen Vaccine Biologics Corp. (MVC), headquartered in Taiwan, h...
CanSino Biologics has announced that China’s National Medical Products Administration has accepted the New Drug Ap...
South Korean biopharmaceutical company Dx&Vx has signed two material transfer agreements in Latin America for its KR...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is collaborating with Hilleman Laboratories, a Singa...
Moderna, Inc. has announced that the US Food and Drug Administration (FDA) has approved mFLUSIVA® (mRNA-1010), a new...
The US Food and Drug Administration has approved Moderna’s mFlusiva seasonal influenza vaccine for adults aged 50 ...
South Korea-based startup Progeneer has signed a non-exclusive licensing agreement worth up to $390 million (approximate...
Takeda has received marketing authorisation from India’s Drug Controller General of India for TAK-003, its dengue ...
A CEPI-backed vaccine candidate developed by the University of Oxford’s Oxford Vaccine Group has become the first ...
Delonix Bioworks has dosed the first participant in its Phase 1 clinical trial of DX-104, a next-generation Group B meni...
Matica Biotechnology has entered a partnership with VaxDome to support development of antigen-agnostic antiviral-vaccine...
US-based biotech company Anixa Biosciences has announced that the Korean Ministry of Intellectual Propert...
China-based CanSino Biologics Inc. has announced that the company's ACYW135 Meningococcal Polysaccharide Conjugate Vacci...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Sanofi, a wor...
The COVID-19 pandemic demonstrated that scientific discovery can move at extraordinary speed, but it also expose...
Despite decades of advances in oncology, many solid tumours remain difficult to treat effectively without exposing patie...
South Korea-based SK bioscience, a global innovative vaccine and biotech company, has announced that, after entering int...
Shionogi has received US FDA approval for XOCOVA, or ensitrelvir, as an oral post-exposure prophylaxis option for COVID-...
Argo Biopharma will present updated Phase II results for BW-20805, its investigational siRNA therapy for hereditary angi...
